Reducing Health Disparities in Appalachians with Multiple Cardiovascular Disease Risk Factors
Wayne Noble, Clinical Research Protocol Manager Debra Moser, Professor and Linda C Gill Chair of Cardiovascular Nursing
@DebraMoser dmoser@uky.edu
Reducing Health Disparities in Appalachians with Multiple - - PowerPoint PPT Presentation
Reducing Health Disparities in Appalachians with Multiple Cardiovascular Disease Risk Factors Wayne Noble, Clinical Research Protocol Manager Debra Moser, Professor and Linda C Gill Chair of Cardiovascular Nursing @DebraMoser dmoser@uky.edu
@DebraMoser dmoser@uky.edu
2
target population, care providers, community leaders, business people prior and after study
groups
research meetings
community of focus
be hypertensive by us
lipid abnormality found on our screening
depressive symptoms (score of > 9 on the PHQ-9) on our screening
for at least 4 days per week
provider for management of the CVD risk factors identified in our screening
1) principles self-care, CVD risk reduction; 2) nutrition (portion control, diet high in fruits and vegetable and whole grains, reducing saturated and trans fats, reducing sodium intake, reducing total fat intake, good fats vs bad fats); 3) physical activity; 4) depression control and stress reduction; 5) managing multiple comorbid risk factors; 6) smoking cessation and/or medication adherence
health workers to groups of 10 people using specific behavior change principles
Endpoint Measure When Measured Screening
Prior to enrollment Specific Aims 1 and 2
Baseline, 4 months, 1 year Specific Aim 3
Baseline, 4 months, 1 year Specific Aim 4
4 months, 1 year Specific Aim 5
recommendations assessed by Medical Outcomes Study Specific Adherence Scale
Baseline, 4 months, 1 year 4 months, 1 year
Baseline Participant Characteristics Compared Between Intervention and Control
Total Sample (N=352) N (%) or mean + SD Control (n=168) N (%) or mean + SD Intervention (n=184) N (%) or mean + SD P Age, years 42.9 + 12.8 43.2 + 12.2 42.6 + 13.4 .652 Female gender 272 (77.3) 126 (75.0) 146 (79.3) .331 Caucasian ethnicity 338 (96.8) 158 (94.6) 180 (98.9) .022 Education, years 13.6 + 2.8 13.5 + 2.7 13.6 + 2.9 .607 Married, cohabitating 210 (60.2) 103 (61.7) 107 (58.8) .582 Yrs lived in Kentucky 39.2 + 13.9 39.3 + 13.8 39.1+14.2 .896 Financial stability Comfortable Make ends meet Not enough 45 (12.9) 213 (61.0) 91 (26.1) 21 (12.6) 95 (56.9) 51 (30.5) 24 (13.2) 118 (64.8) 40 (22.0) .185
Total Sample (N=352) N (%) or mean + SD Control (n=168) N (%) or mean + SD Intervention (n=184) N (%) or mean + SD P Charlson comorbidity score .39 + .86 .35 + .72 .42 + .98 .489 Adequate health literacy 270 (78%) 125 (76.2) 145 (79.7) .439 Smoker (based on urinary cotinine) 147 (41.8) 76 (45.2) 71 (38.6) .206 Body mass index, kg/m2 31.9 + 7.6 31 + 7 32 +8 .169 Framingham risk score, % 9.3 + 8.8 9.4 + 8.7 9.3 + 8.8 .872 Systolic blood pressure, mmHg 137.9 + 19.9 137.8 + 21.3 138.1 + 18.7 .885 Diastolic blood pressure, mmHg 88.3 + 14.7 88.7 +13.9 87.9 + 15.4 .600 Total cholesterol, mg/dL 188.6 + 43.2 185.7 + 41.0 191.3 + 45.1 .227 Low density lipoprotein, mg/dL 105.6 + 33.1 103.7 + 32.5 107.3 + 33.7 .333 High density lipoprotein, mg/dL 46.2 + 14.3 46.4 +14.8 46.1+ 13.9 .869 Triglycerides, mg/dL 187.6 + 121.1 184 + 121 191 +122 .603 Depression score 5.5 + 5.5 5.5 + 5.2 5.5 + 5.8 .966
Specific Aim 2: Comparison of Outcomes Across Time Between Intervention and Usual Care
Outcomes Groups Baseline 4-months 12-months P T x Grp Body mass index Intervention 32.6 ± 7.8 32.3 ± 7.9 32.2 ± 7.9 0.017 Control 31.4 ± 7.4 31.7 ± 7.4 31.9 ± 7.4 Framingham risk score, % Intervention 9.4 ± 8.7 8.3 ± 8.2 7.7 ± 7.4 0 .001 Control 9.8 ± 8.5 10.2 ± 9.3 10.8 ± 9.3 Systolic blood pressure, mmHg Intervention 137.5 ± 18.8 136.6 ± 19.6 128.4 ± 17.2 0 .002 Control 138.3 ± 21.2 131.8 ± 19.2 136.9 ± 22.0 Diastolic blood pressure mmHg Intervention 88.3 ± 13.4 83.3 ± 11.3 80.0 ± 10.5 0.001 Control 89.3 ± 14.0 87.7 ± 12.5 87.1 ± 13.9 Total cholesterol, mg/dL Intervention 191.4 ± 45.1 184.5 ± 44.6 177.9 ± 39.8 0.026 Control 189.9 ± 42.3 184.9 ± 41.3 186.5 ± 40.1 Low density lipoprotein, mg/dL Intervention 109.1 ± 35.6 111.0 ± 118.6 106.1 ± 87.6 0.29 Control 106.4 ± 31.9 99.9 ± 30.1 93.2±28.7 High density lipoprotein, mg/dL Intervention 47.2± 14.0 46.8 ± 13.7 50.2 ± 15.2 0 .022 Control 48.0 ±14.9 46.9 ± 15.5 47.3 ±16.3 Triglycerides, mg/dL Intervention 193.7 ± 124.0 182.1 ± 99.9 184.9 ± 130.7 0.477 Control 189.2 ± 120.8 193.1 ± 118.6 191.4 ± 123.6 Depression scores Intervention 5.4 ± 5.0 4.2 ± 4.4 4.2 ± 5.5 0.019 Control 5.1 ± 5.4 4.8 ± 4.8 5.5 ± 6.1